ATP12A and gastroesophageal reflux disease: The PPIs are potent inhibitors of H+,K+ATPase, the proton pump of the gastric parietal cell [2], and it has been assumed widely that gastric acid inhibition is the sole mechanism underlying the beneficial effects of PPIs in GERD and other acid-peptic disorders.